Methyl prednisolone in the treatment of renal transplant rejection.
D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003609:Dactinomycin / Q000627:therapeutic use; D004341:Drug Evaluation; D006084:Graft Rejection / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007275:Injections, Intravenous; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use*; D011183:Postoperative Complications; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014022:Tissue Survival; D014184:Transplantation, Homologous
D003609:Dactinomycin; D001379:Azathioprine; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone